{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:52:51Z","timestamp":1770645171916,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Science and Technology Development Fund of Egypt","award":["5016"],"award-info":[{"award-number":["5016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4342-5","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T17:05:48Z","timestamp":1525367148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population"],"prefix":"10.1186","volume":"18","author":[{"given":"Nada","family":"Ezzeldin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"El-Lebedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6370-0272","authenticated-orcid":false,"given":"Amira","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"El Bastawisy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen Hamdy","family":"Abd Elaziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirhane Mohamed","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Saad-Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"key":"4342_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359\u201386. https:\/\/doi.org\/10.1002\/ijc.29210 .","journal-title":"Int J Cancer"},{"key":"4342_CR2","first-page":"890","volume":"11","author":"N Ariyoshi","year":"2002","unstructured":"Ariyoshi N, Miyamoto M, Umetsu Y, Kunitoh H, Dosaka-Akita H, Sawamura Y-I, et al. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers. Cancer Epidemiol Biomark Prev. 2002;11:890\u20134.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4342_CR3","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0090-9556(25)08453-3","volume":"24","author":"M Nakajima","year":"1996","unstructured":"Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, et al. Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos. 1996;24:1212\u20137.","journal-title":"Drug Metab Dispos"},{"key":"4342_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF00191161","volume":"47","author":"M Iscan","year":"1994","unstructured":"Iscan M, Rostami H, Iscan M, G\u00fcray T, Pelkonen O, Rautio A. Interindividual variability of coumarin 7-hydroxylation in a Turkish population. Eur J Clin Pharmacol. 1994;47:315\u20138.","journal-title":"Eur J Clin Pharmacol"},{"key":"4342_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00008571-199210000-00005","volume":"2","author":"A Rautio","year":"1992","unstructured":"Rautio A, Kraul H, Kojo A, Salmela E, Pelkonen O. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics. 1992;2:227\u201333.","journal-title":"Pharmacogenetics"},{"key":"4342_CR6","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1093\/carcin\/bgh258","volume":"25","author":"M Fujieda","year":"2004","unstructured":"Fujieda M, Yamazaki H, Saito T, Kiyotani K, Gyamfi MA, Sakurai M, et al. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis. 2004;25:2451\u20138.","journal-title":"Carcinogenesis"},{"key":"4342_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1248\/bpb.b15-00604","volume":"39","author":"M Kumondai","year":"2016","unstructured":"Kumondai M, Hosono H, Orikasa K, Arai Y, Arai T, Sugimura H, et al. Genetic polymorphisms of CYP2A6 in a case-control study on bladder Cancer in Japanese smokers. Biol Pharm Bull. 2016;39:84\u20139.","journal-title":"Biol Pharm Bull"},{"key":"4342_CR8","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1021\/bi00457a031","volume":"29","author":"S Yamano","year":"1990","unstructured":"Yamano S, Tatsuno J, Gonzalez FJ. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry (Mosc). 1990;29:1322\u20139.","journal-title":"Biochemistry (Mosc)"},{"key":"4342_CR9","doi-asserted-by":"publisher","first-page":"17830","DOI":"10.1074\/jbc.M009432200","volume":"276","author":"K Kitagawa","year":"2001","unstructured":"Kitagawa K, Kunugita N, Kitagawa M, Kawamoto T. CYP2A6*6, a novel polymorphism in cytochrome p450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity. J Biol Chem. 2001;276:17830\u20135.","journal-title":"J Biol Chem"},{"key":"4342_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1006\/bbrc.2001.4990","volume":"284","author":"M Pitarque","year":"2001","unstructured":"Pitarque M, von Richter O, Oke B, Berkkan H, Oscarson M, Ingelman-Sundberg M. Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene: impairment of its promoter activity. Biochem Biophys Res Commun. 2001;284:455\u201360.","journal-title":"Biochem Biophys Res Commun"},{"key":"4342_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1006\/bbrc.2001.6209","volume":"290","author":"C Xu","year":"2002","unstructured":"Xu C, Rao YS, Xu B, Hoffmann E, Jones J, Sellers EM, et al. An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles. Biochem Biophys Res Commun. 2002;290:318\u201324.","journal-title":"Biochem Biophys Res Commun"},{"key":"4342_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1046\/j.1365-2125.2002.01667.x","volume":"54","author":"R Yoshida","year":"2002","unstructured":"Yoshida R, Nakajima M, Watanabe Y, Kwon J-T, Yokoi T. Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism. Br J Clin Pharmacol. 2002;54:511\u20137.","journal-title":"Br J Clin Pharmacol"},{"key":"4342_CR13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/thorax.58.7.623","volume":"58","author":"N Minematsu","year":"2003","unstructured":"Minematsu N, Nakamura H, Iwata M, Tateno H, Nakajima T, Takahashi S, et al. Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema. Thorax. 2003;58:623\u20138.","journal-title":"Thorax"},{"key":"4342_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0014-5793(98)01297-6","volume":"438","author":"M Oscarson","year":"1998","unstructured":"Oscarson M, Gullst\u00e9n H, Rautio A, Bernal ML, Sinues B, Dahl ML, et al. Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase. FEBS Lett. 1998;438:201\u20135.","journal-title":"FEBS Lett"},{"key":"4342_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1006\/bbrc.1999.1182","volume":"262","author":"K Kitagawa","year":"1999","unstructured":"Kitagawa K, Kunugita N, Katoh T, Yang M, Kawamoto T. The significance of the homozygous CYP2A6 deletion on nicotine metabolism: a new genotyping method of CYP2A6 using a single PCR\u2013RFLP. Biochem Biophys Res Commun. 1999;262:146\u201351. https:\/\/doi.org\/10.1006\/bbrc.1999.1182 .","journal-title":"Biochem Biophys Res Commun"},{"key":"4342_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.clpt.2004.10.011","volume":"77","author":"V Malaiyandi","year":"2005","unstructured":"Malaiyandi V, Sellers EM, Tyndale RF. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clin Pharmacol Ther. 2005;77:145\u201358. https:\/\/doi.org\/10.1016\/j.clpt.2004.10.011 .","journal-title":"Clin Pharmacol Ther"},{"key":"4342_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.clpt.2006.05.012","volume":"80","author":"M Nakajima","year":"2006","unstructured":"Nakajima M, Fukami T, Yamanaka H, Higashi E, Sakai H, Yoshida R, et al. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin Pharmacol Ther. 2006;80:282\u201397.","journal-title":"Clin Pharmacol Ther"},{"key":"4342_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0014-5793(99)01364-2","volume":"460","author":"M Oscarson","year":"1999","unstructured":"Oscarson M, McLellan RA, Gullst\u00e9n H, Ag\u00fandez JA, Ben\u00edtez J, Rautio A, et al. Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism. FEBS Lett. 1999;460:321\u20137.","journal-title":"FEBS Lett"},{"key":"4342_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00008571-200409000-00006","volume":"14","author":"KA Schoedel","year":"2004","unstructured":"Schoedel KA, Hoffmann EB, Rao Y, Sellers EM, Tyndale RF. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics. 2004;14:615\u201326.","journal-title":"Pharmacogenetics"},{"key":"4342_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000076418","volume":"49","author":"K Iwahashi","year":"2004","unstructured":"Iwahashi K, Waga C, Takimoto T. Whole deletion of CYP2A6 gene (CYP2A6AST;4C) and smoking behavior. Neuropsychobiology. 2004;49:101\u20134.","journal-title":"Neuropsychobiology"},{"key":"4342_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.17179\/excli2016-847","volume":"16","author":"LA L\u00f3pez-Flores","year":"2017","unstructured":"L\u00f3pez-Flores LA, P\u00e9rez-Rubio G, Falf\u00e1n-Valencia R. Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction. EXCLI J. 2017;16:174\u201396. https:\/\/doi.org\/10.17179\/excli2016-847 .","journal-title":"EXCLI J"},{"key":"4342_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1183\/09031936.06.00056305","volume":"27","author":"N Minematsu","year":"2006","unstructured":"Minematsu N, Nakamura H, Furuuchi M, Nakajima T, Takahashi S, Tateno H, et al. Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms. Eur Respir J. 2006;27:289\u201392.","journal-title":"Eur Respir J"},{"key":"4342_CR23","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2217\/14622416.8.10.1385","volume":"8","author":"JC Mwenifumbo","year":"2007","unstructured":"Mwenifumbo JC, Tyndale RF. Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. Pharmacogenomics. 2007;8:1385\u2013402.","journal-title":"Pharmacogenomics"},{"key":"4342_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/carcin\/bgw012","volume":"37","author":"SL Park","year":"2016","unstructured":"Park SL, Tiirikainen MI, Patel YM, Wilkens LR, Stram DO, Le Marchand L, et al. Genetic determinants of CYP2A6 activity across racial\/ethnic groups with different risks of lung cancer and effect on their smoking intensity. Carcinogenesis. 2016;37:269\u201379. https:\/\/doi.org\/10.1093\/carcin\/bgw012 .","journal-title":"Carcinogenesis"},{"key":"4342_CR25","unstructured":"Emamghoreishi M, Bokaee H-R, Keshavarz M, Ghaderi A, Tyndale RF. CYP2A6 allele frequencies in an Iranian population. Arch Iran Med. 2008;11:613\u20137."},{"key":"4342_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00008571-200102000-00005","volume":"11","author":"MA Loriot","year":"2001","unstructured":"Loriot MA, Rebuissou S, Oscarson M, Cen\u00e9e S, Miyamoto M, Ariyoshi N, et al. Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population. Pharmacogenetics. 2001;11:39\u201344.","journal-title":"Pharmacogenetics"},{"key":"4342_CR27","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1006\/bbrc.1999.1089","volume":"261","author":"M Miyamoto","year":"1999","unstructured":"Miyamoto M, Umetsu Y, Dosaka-Akita H, Sawamura Y, Yokota J, Kunitoh H, et al. CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochem Biophys Res Commun. 1999;261:658\u201360.","journal-title":"Biochem Biophys Res Commun"},{"key":"4342_CR28","first-page":"7581","volume":"63","author":"H Takeuchi","year":"2003","unstructured":"Takeuchi H, Saoo K, Yokohira M, Ikeda M, Maeta H, Miyazaki M, et al. Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female a\/J mice. Cancer Res. 2003;63:7581\u20133.","journal-title":"Cancer Res"},{"key":"4342_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/1097-0215(20010320)95:2<96::AID-IJC1017>3.0.CO;2-2","volume":"95","author":"W Tan","year":"2001","unstructured":"Tan W, Chen GF, Xing DY, Song CY, Kadlubar FF, Lin DX. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population. Int J Cancer. 2001;95:96\u2013101.","journal-title":"Int J Cancer"},{"key":"4342_CR30","first-page":"8057","volume":"63","author":"H Wang","year":"2003","unstructured":"Wang H, Tan W, Hao B, Miao X, Zhou G, He F, et al. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Res. 2003;63:8057\u201361.","journal-title":"Cancer Res"},{"key":"4342_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s41021-016-0066-4","volume":"39","author":"N Ezzeldin","year":"2017","unstructured":"Ezzeldin N, El-Lebedy D, Darwish A, El-Bastawisy A, Hassan M, Abd El-Aziz S, et al. Genetic polymorphisms of human cytochrome P450 CYP1A1 in an Egyptian population and tobacco-induced lung cancer. Genes Environ. 2017;39:7. https:\/\/doi.org\/10.1186\/s41021-016-0066-4 .","journal-title":"Genes Environ"},{"key":"4342_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/sj.tpj.6500290","volume":"5","author":"GM Vasconcelos","year":"2005","unstructured":"Vasconcelos GM, Struchiner CJ, Suarez-Kurtz G. CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians. Pharmacogenomics J. 2005;5:42\u20138.","journal-title":"Pharmacogenomics J"},{"key":"4342_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1191\/096032701678766804","volume":"20","author":"I \u00c7ok","year":"2001","unstructured":"\u00c7ok I, Kocaba\u015f NA, Cholerton S, Karakayal AE, \u015earda\u015f S. Dtermination of coumarin metabolism in Turkish population. Hum Exp Toxicol. 2001;20:179\u201384. https:\/\/doi.org\/10.1191\/096032701678766804 .","journal-title":"Hum Exp Toxicol"},{"key":"4342_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/00008571-199906000-00007","volume":"9","author":"GF Chen","year":"1999","unstructured":"Chen GF, Tang YM, Green B, Lin DX, Guengerich FP, Daly AK, et al. Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method. Pharmacogenetics. 1999;9:327\u201332.","journal-title":"Pharmacogenetics"},{"key":"4342_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1067\/mcp.2001.112688","volume":"69","author":"M Nakajima","year":"2001","unstructured":"Nakajima M, Kwon JT, Tanaka N, Zenta T, Yamamoto Y, Yamamoto H, et al. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clin Pharmacol Ther. 2001;69:72\u20138.","journal-title":"Clin Pharmacol Ther"},{"key":"4342_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0300-483X(01)00470-X","volume":"168","author":"T Paschke","year":"2001","unstructured":"Paschke T, Riefler M, Schuler-Metz A, Wolz L, Scherer G, McBride CM, et al. Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method. Toxicology. 2001;168:259\u201368.","journal-title":"Toxicology"},{"key":"4342_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2188\/jea.13.176","volume":"13","author":"M Ando","year":"2003","unstructured":"Ando M, Hamajima N, Ariyoshi N, Kamataki T, Matsuo K, Ohno Y. Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults. J Epidemiol. 2003;13:176\u201381.","journal-title":"J Epidemiol"},{"key":"4342_CR38","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1124\/mol.58.4.747","volume":"58","author":"Y Rao","year":"2000","unstructured":"Rao Y, Hoffmann E, Zia M, Bodin L, Zeman M, Sellers EM, et al. Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking. Mol Pharmacol. 2000;58:747\u201355.","journal-title":"Mol Pharmacol"},{"key":"4342_CR39","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S0140-6736(98)04984-8","volume":"353","author":"SJ London","year":"1999","unstructured":"London SJ, Idle JR, Daly AK, Coetzee GA. Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet. 1999;353:898\u20139.","journal-title":"Lancet"},{"key":"4342_CR40","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1023\/A:1021642323602","volume":"29","author":"SZ Sabol","year":"1999","unstructured":"Sabol SZ, Hamer DH. An improved assay shows no association between the CYP2A6 gene and Cigarette smoking behavior. Behav Genet. 1999;29:257\u201361. https:\/\/doi.org\/10.1023\/A:1021642323602 .","journal-title":"Behav Genet"},{"key":"4342_CR41","doi-asserted-by":"publisher","first-page":"e26668","DOI":"10.1371\/journal.pone.0026668","volume":"6","author":"Z Verde","year":"2011","unstructured":"Verde Z, Santiago C, Rodr\u00edguez Gonz\u00e1lez-Moro JM, de Lucas RP, L\u00f3pez Mart\u00edn S, Bandr\u00e9s F, et al. \u201cSmoking genes\u201d: a genetic association study. PLoS One. 2011;6:e26668.","journal-title":"PLoS One"},{"issue":"Pt 5","key":"4342_CR42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1469-1809.2000.6450383.x","volume":"64","author":"DF Gu","year":"2000","unstructured":"Gu DF, Hinks LJ, Morton NE, Day IN. The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit. Ann Hum Genet. 2000;64(Pt 5):383\u201390.","journal-title":"Ann Hum Genet"},{"key":"4342_CR43","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/clpt.2010.3","volume":"87","author":"C Lerman","year":"2010","unstructured":"Lerman C, Jepson C, Wileyto EP, Patterson F, Schnoll R, Mroziewicz M, et al. Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy. Clin Pharmacol Ther. 2010;87:553\u20137.","journal-title":"Clin Pharmacol Ther"},{"key":"4342_CR44","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.clpt.2006.02.006","volume":"79","author":"C Lerman","year":"2006","unstructured":"Lerman C, Tyndale R, Patterson F, Wileyto EP, Shields PG, Pinto A, et al. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther. 2006;79:600\u20138.","journal-title":"Clin Pharmacol Ther"},{"key":"4342_CR45","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/sj.mp.4001794","volume":"11","author":"V Malaiyandi","year":"2006","unstructured":"Malaiyandi V, Lerman C, Benowitz NL, Jepson C, Patterson F, Tyndale RF. Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Mol Psychiatry. 2006;11:400\u20139.","journal-title":"Mol Psychiatry"},{"key":"4342_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1158\/1055-9965.EPI-10-0674","volume":"20","author":"AA Strasser","year":"2011","unstructured":"Strasser AA, Benowitz NL, Pinto AG, Tang KZ, Hecht SS, Carmella SG, et al. Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level. Cancer Epidemiol Biomark Prev. 2011;20:234\u20138.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4342_CR47","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3109\/10826084.2013.778280","volume":"48","author":"MA Styn","year":"2013","unstructured":"Styn MA, Nukui T, Romkes M, Perkins KA, Land SR, Weissfeld JL. CYP2A6 genotype and smoking behavior in current smokers screened for lung cancer. Subst Use Misuse. 2013;48:490\u20134.","journal-title":"Subst Use Misuse"},{"key":"4342_CR48","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1093\/jnci\/djr237","volume":"103","author":"CA Wassenaar","year":"2011","unstructured":"Wassenaar CA, Dong Q, Wei Q, Amos CI, Spitz MR, Tyndale RF. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. J Natl Cancer Inst. 2011;103:1342\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"4342_CR49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/14622200410001676387","volume":"6","author":"B Carter","year":"2004","unstructured":"Carter B, Long T, Cinciripini P. A meta-analytic review of the CYP2A6 genotype and smoking behavior. Nicotine Tob Res. 2004;6:221\u20137.","journal-title":"Nicotine Tob Res"},{"key":"4342_CR50","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/14622200410001734030","volume":"6","author":"M Munaf\u00f2","year":"2004","unstructured":"Munaf\u00f2 M, Clark T, Johnstone E, Murphy M, Walton R. The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res. 2004;6:583\u201397.","journal-title":"Nicotine Tob Res"},{"key":"4342_CR51","unstructured":"Smoking in Egypt | Egypt Independent. http:\/\/www.egyptindependent.com\/news\/smoking-egypt . Accessed 18 Apr 2017."},{"key":"4342_CR52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4236\/ojepi.2015.52017","volume":"05","author":"CA Loffredo","year":"2015","unstructured":"Loffredo CA, Radwan GN, Eltahlawy EM, El-Setouhy M, Magder L, Hussein MH. Estimates of the prevalence of tobacco smoking in Egypt. Open J Epidemiol. 2015;05:129. https:\/\/doi.org\/10.4236\/ojepi.2015.52017 .","journal-title":"Open J Epidemiol"},{"key":"4342_CR53","first-page":"4858","volume":"58","author":"L Le Marchand","year":"1998","unstructured":"Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR, et al. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res. 1998;58:4858\u201363.","journal-title":"Cancer Res"},{"key":"4342_CR54","first-page":"5284","volume":"54","author":"EL Wynder","year":"1994","unstructured":"Wynder EL, Hoffmann D. Smoking and lung cancer: scientific challenges and opportunities. Cancer Res. 1994;54:5284\u201395.","journal-title":"Cancer Res"},{"key":"4342_CR55","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/14622200701239605","volume":"9","author":"AA Strasser","year":"2007","unstructured":"Strasser AA, Malaiyandi V, Hoffmann E, Tyndale RF, Lerman C. An association of CYP2A6 genotype and smoking topography. Nicotine Tob Res. 2007;9:511\u20138.","journal-title":"Nicotine Tob Res"},{"key":"4342_CR56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/carcin\/bgu235","volume":"36","author":"CA Wassenaar","year":"2015","unstructured":"Wassenaar CA, Ye Y, Cai Q, Aldrich MC, Knight J, Spitz MR, et al. CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations. Carcinogenesis. 2015;36:99\u2013103.","journal-title":"Carcinogenesis"},{"key":"4342_CR57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/jnci\/94.2.108","volume":"94","author":"NL Benowitz","year":"2002","unstructured":"Benowitz NL, P\u00e9rez-Stable EJ, Herrera B, Jacob P. Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. J Natl Cancer Inst. 2002;94:108\u201315.","journal-title":"J Natl Cancer Inst"},{"key":"4342_CR58","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.acra.2011.02.016","volume":"18","author":"D Wang","year":"2011","unstructured":"Wang D, Gaba RC, Jin B, Riaz A, Lewandowski RJ, Ryu RK, et al. Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinoma. Acad Radiol. 2011;18:828\u201336.","journal-title":"Acad Radiol"},{"key":"4342_CR59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1515\/dmdi-2012-0001","volume":"27","author":"H Raunio","year":"2012","unstructured":"Raunio H, Rahnasto-Rilla M. CYP2A6: genetics, structure, regulation, and function. Drug Metabol Drug Interact. 2012;27:73\u201388.","journal-title":"Drug Metabol Drug Interact"},{"key":"4342_CR60","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/em.21751","volume":"54","author":"T Liu","year":"2013","unstructured":"Liu T, Xie C-B, Ma W-J, Chen W-Q. Association between CYP2A6 genetic polymorphisms and lung cancer: a meta-analysis of case-control studies. Environ Mol Mutagen. 2013;54:133\u201340.","journal-title":"Environ Mol Mutagen"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4342-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4342-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4342-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T03:18:13Z","timestamp":1751599093000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4342-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,3]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4342"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4342-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,3]]},"assertion":[{"value":"13 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol &the informed consent form were submitted for approval by Medical Research Ethics Committee (MREC) of National Research Centerof Egypt prior to the study commencement, with approval granted in January 2014 (Ref,-NO. 14008).All subjects were aware of the study protocol and gave written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"525"}}